The cardioprotective effects of NS1619 against ischemic damage may be due to pharmacological preconditioning through inhibition of the mitochondrial respiratory chain.
No takes yet. Share an insight, caveat, or question.
May explain NS1619 cardioprotection via preconditioning in animal ischemia; hypothesis-generating for human translation.
Kicińska et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: